UZH researchers harness AI to detect antibiotic resistance

Researchers at the University of Zurich (UZH) have used artificial intelligence (AI) to help identify antibiotic-resistant bacteria.

FDA approves Pfizer’s HYMPAVZI to treat haemophilia

The FDA approval of HYMPAVZI was supported by the Phase III BASIS clinical trial. Credit: Andrey_Popov/Shutterstock. Pfizer has announced the approval of HYMPAVZI (marstacimab-hncq) by

October 14, 2024

Colombian government explores compulsory licensing for an HIV drug

The latest clash over the cost of a prescription medicine is playing out in Colombia, where the government is exploring the possibility of issuing a

July 17, 2023

Teva factored IRA’s next round of negotiations into its growth plans

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.